Elevated levels of amniotic fluid alpha-fetoprotein: sonographic evaluation

Area of Science:

• Prenatal Diagnostics
• Medical Imaging
• Biochemistry

Background:

• Elevated amniotic fluid alpha-fetoprotein (AF-AFP) is a key indicator for potential fetal abnormalities.
• Genetic amniocentesis is a common procedure for prenatal genetic testing.

Purpose of the Study:

• To evaluate the effectiveness of combining AF-AFP screening with targeted fetal sonography for detecting fetal anomalies.
• To assess the diagnostic accuracy and programmatic impact of this combined approach.

Main Methods:

• Retrospective analysis of 263 fetuses with elevated AF-AFP levels (> 2.0 multiples of the median) from 1978 to 1990.
• Targeted fetal sonography was performed on all identified cases.
• Comparison of sonographic findings with confirmed diagnoses.

Main Results:

• Sonography identified 32 open neural-tube defects (including 20 myelomeningoceles) and depicted 94% of anomalous fetuses.
• The combined approach (AF-AFP + sonography) achieved a 99% accuracy in distinguishing normal from anomalous fetuses.
• Programmatically, 97% of anomalous fetuses were recognized, with three misdiagnoses corrected postnatally.

Conclusions:

• The combination of elevated AF-AFP levels and detailed fetal sonography is highly effective for detecting and characterizing fetal anomalies.
• This diagnostic strategy facilitates early recognition of fetal abnormalities and normal physiological elevations of AF-AFP.
• The approach significantly improves prenatal diagnostic accuracy, leading to timely interventions and normal developmental outcomes.